1. Home
  2. BGC vs OGN Comparison

BGC vs OGN Comparison

Compare BGC & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BGC
  • OGN
  • Stock Information
  • Founded
  • BGC 1945
  • OGN 1923
  • Country
  • BGC United States
  • OGN United States
  • Employees
  • BGC N/A
  • OGN 10000
  • Industry
  • BGC Investment Bankers/Brokers/Service
  • OGN Biotechnology: Pharmaceutical Preparations
  • Sector
  • BGC Finance
  • OGN Health Care
  • Exchange
  • BGC Nasdaq
  • OGN Nasdaq
  • Market Cap
  • BGC 4.7B
  • OGN 3.9B
  • IPO Year
  • BGC 1999
  • OGN N/A
  • Fundamental
  • Price
  • BGC $8.92
  • OGN $14.91
  • Analyst Decision
  • BGC Buy
  • OGN Hold
  • Analyst Count
  • BGC 1
  • OGN 3
  • Target Price
  • BGC $12.00
  • OGN $21.33
  • AVG Volume (30 Days)
  • BGC 3.3M
  • OGN 2.9M
  • Earning Date
  • BGC 02-12-2025
  • OGN 02-13-2025
  • Dividend Yield
  • BGC 0.89%
  • OGN 7.65%
  • EPS Growth
  • BGC 568.68
  • OGN 120.97
  • EPS
  • BGC 0.24
  • OGN 5.04
  • Revenue
  • BGC $2,119,639,000.00
  • OGN $6,409,000,000.00
  • Revenue This Year
  • BGC $17.19
  • OGN $3.11
  • Revenue Next Year
  • BGC $10.16
  • OGN $2.55
  • P/E Ratio
  • BGC $36.97
  • OGN $2.93
  • Revenue Growth
  • BGC 13.11
  • OGN 4.21
  • 52 Week Low
  • BGC $6.22
  • OGN $13.14
  • 52 Week High
  • BGC $11.79
  • OGN $23.10
  • Technical
  • Relative Strength Index (RSI)
  • BGC 32.60
  • OGN 42.91
  • Support Level
  • BGC $8.90
  • OGN $14.53
  • Resistance Level
  • BGC $9.20
  • OGN $15.41
  • Average True Range (ATR)
  • BGC 0.22
  • OGN 0.52
  • MACD
  • BGC -0.05
  • OGN 0.02
  • Stochastic Oscillator
  • BGC 4.91
  • OGN 31.89

About BGC BGC Group Inc.

BGC Group Inc is a brokerage and financial technology company that serves the global financial markets, energy and commodities markets. Its service and product offerings include brokerage for a wide range of financial products including fixed income, equities, commodities, derivatives, and real estate, software solutions for trading platforms, clearing, trade execution, and other back-office services. Its clients mostly include banks, financial institutions and corporate clients. BGC operates in one reportable segment, which is providing brokerage services. Geographically the company generates revenue from Asia, Other Europe/MEA, France, Other Americas with the majority of its revenue coming from United Kingdom followed by the United States.

About OGN Organon & Co.

Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Share on Social Networks: